BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29226947)

  • 1. Phenotype expansion and development in Kosaki overgrowth syndrome.
    Gawliński P; Pelc M; Ciara E; Jhangiani S; Jurkiewicz E; Gambin T; Różdżyńska-Świątkowska A; Dawidziuk M; Coban-Akdemir ZH; Guilbride DL; Muzny D; Lupski JR; Krajewska-Walasek M
    Clin Genet; 2018 Apr; 93(4):919-924. PubMed ID: 29226947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kosaki overgrowth syndrome: A newly identified entity caused by pathogenic variants in platelet-derived growth factor receptor-beta.
    Takenouchi T; Okuno H; Kosaki K
    Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):650-657. PubMed ID: 31710779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kosaki overgrowth syndrome: A novel pathogenic variant in PDGFRB and expansion of the phenotype including cerebrovascular complications.
    Foster A; Chalot B; Antoniadi T; Schaefer E; Keelagher R; Ryan G; Thomas Q; Philippe C; Bruel AL; Sorlin A; Thauvin-Robinet C; Bardou M; Luu M; Quenardelle V; Wolff V; Woodley J; Vabres P; Lim D; Igbokwe R; Joseph A; Walker H; Jester A; Ellenbogen J; Johnson D; Rooke B; Moss C; Cole T; Faivre L
    Clin Genet; 2020 Jul; 98(1):19-31. PubMed ID: 32291752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of the phenotype of Kosaki overgrowth syndrome.
    Minatogawa M; Takenouchi T; Tsuyusaki Y; Iwasaki F; Uehara T; Kurosawa K; Kosaki K; Curry CJ
    Am J Med Genet A; 2017 Sep; 173(9):2422-2427. PubMed ID: 28639748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive cerebral and coronary aneurysms in the original two patients with Kosaki overgrowth syndrome.
    Takenouchi T; Kodo K; Yamazaki F; Nakatomi H; Kosaki K
    Am J Med Genet A; 2021 Mar; 185(3):999-1003. PubMed ID: 33382209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kosaki Overgrowth Syndrome: Report of a Family with a Novel
    Mutlu Albayrak H; Calder AD
    Mol Syndromol; 2022 Feb; 13(1):38-44. PubMed ID: 35221873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Segmental overgrowth and aneurysms due to mosaic PDGFRB p.(Tyr562Cys).
    Chenbhanich J; Hu Y; Hetts S; Cooke D; Dowd C; Devine P; ; Russell B; Kang SHL; Chang VY; Abla AA; Cornett P; Yeh I; Lee H; Martinez-Agosto JA; Frieden IJ; Shieh JT
    Am J Med Genet A; 2021 May; 185(5):1430-1436. PubMed ID: 33683022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive activation of the PI3K-AKT pathway and cardiovascular abnormalities in an individual with Kosaki overgrowth syndrome.
    Zarate YA; Boccuto L; Srikanth S; Pauly R; Ocal E; Balmakund T; Hinkle K; Stefans V; Schaefer GB; Collins RT
    Am J Med Genet A; 2019 Jun; 179(6):1047-1052. PubMed ID: 30941910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole exome sequencing identifies the first STRADA point mutation in a patient with polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome (PMSE).
    Bi W; Glass IA; Muzny DM; Gibbs RA; Eng CM; Yang Y; Sun A
    Am J Med Genet A; 2016 Aug; 170(8):2181-5. PubMed ID: 27170158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kosaki overgrowth syndrome due to a novel de novo PDGFRB variant.
    Hernández Dorronsoro U; Gawlinski P; Lasa-Aranzasti A; Martínez-Soroa I; Artola Aizalde E; Saez Villaverde R; Aguirre Rodríguez C; Satrustegi Aritziturri M
    Clin Genet; 2022 Jan; 101(1):144-145. PubMed ID: 34708400
    [No Abstract]   [Full Text] [Related]  

  • 11. Positive response to imatinib in PDGFRB-related Kosaki overgrowth syndrome.
    Rustad CF; Tveten K; Prescott TE; Bjerkeseth PO; Bredrup C; Pfeiffer HCV
    Am J Med Genet A; 2021 Aug; 185(8):2597-2601. PubMed ID: 33979467
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel overgrowth syndrome phenotype due to recurrent de novo PDGFRB mutation.
    Takenouchi T; Yamaguchi Y; Tanikawa A; Kosaki R; Okano H; Kosaki K
    J Pediatr; 2015 Feb; 166(2):483-6. PubMed ID: 25454926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT1 modulates tissue wasting or overgrowth downstream from PDGFRβ.
    He C; Medley SC; Kim J; Sun C; Kwon HR; Sakashita H; Pincu Y; Yao L; Eppard D; Dai B; Berry WL; Griffin TM; Olson LE
    Genes Dev; 2017 Aug; 31(16):1666-1678. PubMed ID: 28924035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A patient with germ-line gain-of-function PDGFRB p.N666H mutation and marked clinical response to imatinib.
    Pond D; Arts FA; Mendelsohn NJ; Demoulin JB; Scharer G; Messinger Y
    Genet Med; 2018 Jan; 20(1):142-150. PubMed ID: 28726812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukoencephalopathy in RIN2 syndrome: Novel mutation and expansion of clinical spectrum.
    Kameli R; Ashrafi MR; Ehya F; Alizadeh H; Hosseinpour S; Garshasbi M; Tavasoli AR
    Eur J Med Genet; 2020 Jan; 63(1):103629. PubMed ID: 30769224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel de novo PDGFRB variant in a child with severe cerebral malformations, intracerebral calcifications, and infantile myofibromatosis.
    Guimier A; Gordon CT; Hully M; Blauwblomme T; Minard-Colin V; Bole-Feysot C; Nitschké P; Oufadem M; Boddaert N; Sarnacki S; Amiel J
    Am J Med Genet A; 2019 Jul; 179(7):1304-1309. PubMed ID: 31004414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.
    Mirzaa GM; Campbell CD; Solovieff N; Goold C; Jansen LA; Menon S; Timms AE; Conti V; Biag JD; Adams C; Boyle EA; Collins S; Ishak G; Poliachik S; Girisha KM; Yeung KS; Chung BHY; Rahikkala E; Gunter SA; McDaniel SS; Macmurdo CF; Bernstein JA; Martin B; Leary R; Mahan S; Liu S; Weaver M; Doerschner M; Jhangiani S; Muzny DM; Boerwinkle E; Gibbs RA; Lupski JR; Shendure J; Saneto RP; Novotny EJ; Wilson CJ; Sellers WR; Morrissey M; Hevner RF; Ojemann JG; Guerrini R; Murphy LO; Winckler W; Dobyns WB
    JAMA Neurol; 2016 Jul; 73(7):836-845. PubMed ID: 27159400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Segmental overgrowth syndrome due to an activating PIK3CA mutation identified in affected muscle tissue by exome sequencing.
    Rasmussen M; Sunde L; Weigert KP; Bogaard PW; Lildballe DL
    Am J Med Genet A; 2014 May; 164A(5):1318-21. PubMed ID: 24665065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pitfalls in the diagnosis of segmental overgrowth syndromes: a child with the c.2740G > A mutation in PIK3CA gene.
    Maguolo A; Antoniazzi F; Spano A; Fiorini E; Gaudino R; Mauro M; Cantalupo G; Biban P; Maitz S; Cavarzere P
    Ital J Pediatr; 2018 Sep; 44(1):110. PubMed ID: 30231930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel ACVR1 mutation detected by whole exome sequencing in a family with an unusual skeletal dysplasia.
    Rafati M; Mohamadhashem F; Hoseini A; Hoseininasab F; Ghaffari SR
    Eur J Med Genet; 2016 Jun; 59(6-7):330-6. PubMed ID: 27182040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.